INOVIO PHARMACEUTICALS, INC. (INO) Free cash flow 2016–2025
INOVIO PHARMACEUTICALS, INC. (INO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$88.9MFY2025 · since FY2016: -$65.3M → -$88.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$88.9M | +15.0% |
| FY2024 | -$104.6M | +16.1% |
| FY2023 | -$124.7M | +42.6% |
| FY2022 | -$217.2M | -0.1% |
| FY2021 | -$216.9M | -20.9% |
| FY2020 | -$179.5M | -81.6% |
| FY2019 | -$98.8M | -30.7% |
| FY2018 | -$75.6M | -2.9% |
| FY2017 | -$73.5M | -12.6% |
| FY2016 | -$65.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice